Taysha Gene Therapies Inc (NAS:TSHA)
$ 2.05 0.03 (1.49%) Market Cap: 420.13 Mil Enterprise Value: 298.96 Mil PE Ratio: 0 PB Ratio: 3.80 GF Score: 27/100

Taysha Gene Therapies Inc at Jefferies Gene Therapy/Editing Summit (Virtual) Transcript

Oct 28, 2021 / 03:00PM GMT
Release Date Price: $16.25 (+0.49%)
Eun Yang
(Trades, Portfolio) LLC - Analyst

Good morning, everyone. This is Eun Yang at Jefferies. I'll be hosting a fireside chat with the Taysha team: RA Session, CEO; and Suyash Prasad, Chief Medical Officer and Head of R&D. So, RA and Suyash, thank you for joining us today for the discussion.

RA Session
Taysha Gene Therapies, Inc. - CEO

Thanks for having us.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot